Alcon may pay $95 million in dispute over phaco patents

Webb, Jennifer A.
June 2005
Ophthalmology Times;6/15/2005, Vol. 30 Issue 12, p3
Trade Publication
Reports that a U.S. jury has ordered Alcon Laboratories Inc. (ALI) to pay Advanced Medical Optics Inc. (AMO), for what it found to be willful infringement of two patents for phacoemulsification equipment used during cataract surgery. Use of patented information relating to the occlusion mode on the Infiniti Vision System of ALI; Violation of patents for the fluidics management system on the Infiniti and the Series 20000 AdvanTec by ALI; Plan of AMO to seek a permanent injunction to block the sales of these devices.


Related Articles

  • Ultrasound mode key to safer phaco. Charters, Lynda // Ophthalmology Times;1/15/2005, Vol. 30 Issue 2, p12 

    This article reports that a low power divide and conquer technique using the Infmiti Vision System, (Alcon Laboratories) in linear burst mode provided exceptional surgeon control and low ultrasound power in the eye compared with the Legacy system linear continuous mode. In a study of the...

  • Liquefaction device is good alternative for cataract surgery. Yoo, Sonia H. // Ophthalmology Times;8/15/2005, Vol. 30 Issue 16, p46 

    Recommends the AquaLase liquefaction device from Alcon Laboratories Inc. to cataract surgeons performing standard ultrasound phacoemulsification. Advantages of the AquaLase device in terms of enhancing the safety of lens removal; Features of the device; Efficacy and safety of the product.

  • Unique model illustrates fluidic flow during torsional phaco. Solomon, Kerry D. // Ophthalmology Times;10/1/2006, Vol. 31 Issue 19, p56 

    The article focuses on the usefulness of the OZil handpiece from Alcon Laboratories Inc. in the fluidic flow during torsional phacoemulsification. The handpiece is the newest incarnation of a phacoemulsification process that has remained virtually unchanged for 4 decades, since Charles Kelman...

  • Alcon, AMO agree to cross-licensing arrangement.  // Ophthalmology Times;8/1/2008, Vol. 33 Issue 15, p8 

    The article discusses the prepared statement of Alcon Laboratories and Advanced Medical Optics (AMO) which states that they agreed to a patent cross licensing agreement for insertion devices in Switzerland and California. Under the licensing agreement, AMO is required to pay Alcon $10 million...

  • Alcon, AMO settle pending patent litigation. Webb, Jennifer A. // Ophthalmology Times;9/15/2006, Vol. 31 Issue 18, p6 

    The article reports on the agreement between Alcon Laboratories Inc. and Advanced Medical Optics Inc. to settle the pending patent litigation involving the two companies in the U.S. Alcon Laboratories has agreed to pay Advanced $121 million as part of a global settlement agreement that resolves...

  • 2007 largely spectacular for cataract surgery. Guttman, Cheryl // Ophthalmology Times;12/1/2007, Vol. 32 Issue 23, p16 

    The article presents information on the progress in cataract surgery in 2007. During the year, two new phacoemulsification platforms, WhiteStar Signature from Advanced Medical Optics Inc. (AMO) and Stellaris Vision Enhancement System from Bausch & Lomb Inc. (B&L), were introduced. During the...

  • Difficult cataract cases aided by use of OVD. Modi, Satish // Ophthalmology Times;6/15/2006, Vol. 31 Issue 12, p42 

    The article compares the effectiveness of two ophthalmic viscosurgical device (OVD) in treating patients who are at risk for intraoperative floppy iris syndrome (IFIS) for taking tamsulin hydrochloride. The performance of DisCoVisc of Alcon Laboratories Inc. and Healon 5 of Advanced Medical...

  • AMO, Alcon in dispute over phaco patents.  // Ophthalmology Times;1/1/2004, Vol. 29 Issue 1, p4 

    Reports that Advanced Medical Optics (AMO) is claiming that Alcon's Infiniti and AdvanTec Legacy phacoemulsification systems infringe AMO patents for advanced fluidics technologies in the removal of cataracts. Complaint filed on December 3, 2003 in the U.S. District Court of Delaware;...

  • Cataract and Refractive Surgery.  // Current Medical Literature: Ophthalmology;2009, Vol. 19 Issue 3, p100 

    This section presents information on studies dealing with cataract and refractive surgery. A review containing summary of formulae that can correct effect of refractive surgery to patients who underwent cataract surgery is presented. Patients undergoing cataract surgery at Bristol Eye Infirmary...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics